Avidity Partners Management LP

SEC CIK: 0001791827
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by Avidity Partners Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overview All 13F holders of DNLI Full Q2 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of DNLI by Avidity Partners Management LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−282,752−100.0%	Sold out	Holders
Q2 2023	282,752	$8.34M	0.3%	+282,752	New	Holders
Q3 2021	0	$0	0.0%	−86,100−100.0%	Sold out	Holders
Q2 2021	86,100	$6.75M	0.2%	+86,100	New	Holders